Intercure Ltd (NASDAQ: INCR) has a higher price-to-earnings ratio of 13.01x compared to its average ratio. INCR has 36-month beta value of 0.95. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 2 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for INCR is 25.56M, and currently, short sellers hold a 0.10% ratio of that float. The average trading volume of INCR on August 19, 2024 was 34.75K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
INCR) stock’s latest price update
The stock price of Intercure Ltd (NASDAQ: INCR) has dropped by -9.04 compared to previous close of 1.88. Despite this, the company has seen a fall of -16.99% in its stock price over the last five trading days. seekingalpha.com reported 2024-06-30 that InterCure is a leading pharmaceutical/medical cannabis company based in Israel and a global leader outside North America. Despite the damage the Hamas attack and the state of war in Israel caused, the company managed to sustain operations and present a positive 2023 ER. The company is entitled to full compensation from the Israeli government for the damage taken.
INCR’s Market Performance
Intercure Ltd (INCR) has seen a -16.99% fall in stock performance for the week, with a -25.00% decline in the past month and a -45.63% plunge in the past quarter. The volatility ratio for the week is 8.01%, and the volatility levels for the past 30 days are at 4.88% for INCR. The simple moving average for the past 20 days is -20.50% for INCR’s stock, with a -14.23% simple moving average for the past 200 days.
Analysts’ Opinion of INCR
Many brokerage firms have already submitted their reports for INCR stocks, with Canaccord Genuity repeating the rating for INCR by listing it as a “Buy.” The predicted price for INCR in the upcoming period, according to Canaccord Genuity is $13 based on the research report published on May 18, 2022 of the previous year 2022.
INCR Trading at -23.34% from the 50-Day Moving Average
After a stumble in the market that brought INCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.03% of loss for the given period.
Volatility was left at 4.88%, however, over the last 30 days, the volatility rate increased by 8.01%, as shares sank -25.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.94% lower at present.
During the last 5 trading sessions, INCR fell by -16.99%, which changed the moving average for the period of 200-days by +62.86% in comparison to the 20-day moving average, which settled at $2.1215. In addition, Intercure Ltd saw 32.58% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for INCR
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.29 for the gross margin
The net margin for Intercure Ltd stands at -0.17. The total capital return value is set at -0.0. Equity return is now at value 4.37, with 2.64 for asset returns.
Based on Intercure Ltd (INCR), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -0.27. The debt to equity ratio resting at 0.42. The interest coverage ratio of the stock is -0.13.
Currently, EBITDA for the company is 46.57 million with net debt to EBITDA at 11.46. When we switch over and look at the enterprise to sales, we see a ratio of 1.06. The receivables turnover for the company is 5.82for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.90.
Conclusion
To put it simply, Intercure Ltd (INCR) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
